glp 1 receptor agonist heart failure GLP-1 Agonists in JCI - Cardioprotective GLP-1 metabolite

found that GLP-1R activation reduced tumor growth and metastatic potential by inhibiting ERK1/2 and AKT phosphorylation, lowering MMP-2 and MMP-9 expression, and increasing E-cadherin

5A), with a 10% drop in body weight for the highest dose, and an 8% reduction with the 10 and 5 nmol/kg doses relative to vehicle-treated PWA mice (Fig

prepared the data, conducted the statistical analysis, and made the figures and tables

Additionally, they slow gastric emptying, which means people feel full longer and ultimately eat less

[DOI] [PubMed] [Google Scholar] 49.Mundil D, Cameron-Vendrig A, Husain M

[DOI] [PMC free article] [PubMed] [Google Scholar] 69.Allison DB, Gadde KM, Garvey WT, et al